Reported 14 days ago
Novo Nordisk CEO Lars Fruergaard Jørgensen testified before Congress regarding the prices of the company's GLP-1 drugs, amidst growing scrutiny and questions from lawmakers about their affordability and market impact.
Source: YAHOO